- Filed
- Jun 26, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jun 20, 2025 | 22.22M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 25.28M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 22.22M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $19.45K |
| Capex | Q1 2025 · Mar 31, 2024 | $18.83K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | $158.14K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $561.58K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $2.36M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $2.22M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $2.11M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $2.19M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $3.09M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.32M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $13.93M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $14.55M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.76M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.99M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $16.29M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $16.77M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.01 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | $0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $424.41K |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $577.29K |
| Net Income | Q1 2025 · Mar 31, 2025 | $130.63K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$86.48K |
| Operating Income | Q1 2025 · Mar 31, 2025 | $501.64K |
| Operating Income | Q1 2025 · Mar 31, 2024 | $432.2K |
| Revenue | Q1 2025 · Mar 31, 2025 | $3.76M |
| Revenue | Q1 2025 · Mar 31, 2024 | $3.67M |